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A B S T R A C T   
Acute Colonic Pseudo-obstruction (ACPO), or Ogilvie Syndrome, is a rare phenomenon where acute colonic 
distension occurs, in the absence of mechanical obstruction. Several post-operative cases of Ogilvie Syndrome are 
noted within the literature, pertaining to patients post hepatectomy, trauma or spinal surgery; but rarely 
following urological procedures. This case describes a 68-year-old gentleman who developed Ogilvie Syndrome 
post an uncomplicated robot-assisted radical prostatectomy (RARP). While bowel injury is an acknowledged rare 
complication following prostatectomy, patients with Ogilvie Syndrome may present in a similar manner, and an 
atypical case of colonic obstruction should raise suspicion of this as a cause.   
1. Introduction 
Ogilvie Syndrome, first coined by William Ogilvie FRCS in 1948, 
refers to significant colonic dilation without anatomical evidence of 
obstruction. Evidence has not yet revealed a single conclusive factor, 
instead attributing precipitants such as systemic illness, operative insult, 
and medications as contributing to dysfunction of the enteric nervous 
system, with concurrent autonomic imbalance (increased sympathetic 
activation, and impaired parasympathetic effect). 
2. Case presentation 
A 68-year-old patient was referred to a specialist oncological hospital 
with prostate cancer for consideration of prostatectomy. Pre-operative 
investigation yielded localised Gleason Grade Group 2 disease (Glea-
son 3 + 4 = 7), with an initial PSA of 9.2 and no evidence of lymphatic 
spread. 
His medical history was significant for ischemic heart disease, hy-
pertension, and well-controlled Type 2 diabetes. Medications included 
aspirin, irbesartan, metformin, metoprolol, and pravastatin. There was 
no pertinent gastrointestinal history, including of dysmotility. 
The patient underwent a Robot-Assisted Radical Prostatectomy 
(RARP). The procedure was straightforward and utilised a six-port 
approach – with an open Hassan entry and five instrument ports 
inserted under vision. Bilateral nerve sparing was achieved, and oper-
ating time was 3.5 hours. He was admitted overnight, and discharged 
day 1 post-operatively with aperients and a small quantity of oxycodone 
PRN, with a plan for a trial of void within two weeks. 
Day 4 post-operatively, he re-presented with worsening nausea, 
abdominal pain, and haematuria. An absence of bowel movements was 
noted, despite having been discharged with regular aperients. 
On examination, the abdomen was distended and hyper-tympanic, 
despite resolving pain. Investigations at the time yielded an elevated 
white cell count, and an X-Ray/CT of the abdomen yielded a dilated 
caecum (>11cm), with total collapse of the descending colon and 
rectum, but no transition point (Fig. 1). 
Conservative management was commenced for a presumed bowel 
obstruction with bowel rest. Nasogastric drainage yielded dark bilious 
output. A CT with rectal contrast (Fig. 2) did not suggest any rectal or 
large bowel injury. 
Colonoscopy was undertaken on D2 post re-admission, which yielded 
sloughy, hyperaemic mucosa in the ascending colon, but no site of 
anatomical obstruction. 
Repeat CT imaging (Fig. 3) showed resolving colonic dilation, 
without obstruction, suggestive of acute colonic pseudo-obstruction. 
Regular aperients were prescribed, including sodium picosulfate to 
good effect. Metoclopramide was provided regularly for nausea and pro- 
kinetic effect. Given gradual clinical improvement, a trial of neostigmine 
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was not required. Near-normal oral intake was established D7-8 of re- 
admission, and the patient was discharged home, D12 post re-admission. 
On follow-up, the histology yielded acinar adenocarcinoma with a 
2.6 cc tumour and uninvolved margins/no extra-prostatic extension 
(pT2). There were no ongoing issues with bowel motility. 
3. Discussion 
Ogilvie Syndrome/acute colonic pseudo-obstruction (ACPO) is a 
rare, poorly understood phenomenon of colonic dysmotility, leading to 
obstructive symptoms without an anatomical lesion. Initial theories 
suggested disruption of normal colonic transit, due to autonomic 
dysfunction. Although specific precipitants have not been fully eluci-
dated, patients range from those undergoing major surgical procedures, 
to the critically unwell. Other theories include neuropraxia from retro-
peritoneal complications such as haemorrhage, or secondary to pneu-
moperitoneum. Key complications include perforation, which may 
necessitate resection and defunctioning. In critically unwell patients this 
may contribute significantly to morbidity/mortality – with literature 
suggesting up to 40–50% mortality in perforated pseudo-obstruction.1 
Management is largely supportive, aimed at preventing colonic 
perforation. Studies have purported a benefit in neostigmine, which 
through inhibition of acetylcholinesterase, potentiates nicotinic and 
muscarinic stimulation, encouraging colonic motility. In a double- 
blinded randomized controlled trial by Ponec et al.,2 (treatment group 
- 2.0mg neostigmine bolus; control group – saline), the benefit shown 
was stark. 10/11 patients in the intervention group resolved, comparted 
to 0/10 in the placebo group (p < 0.001). Furthermore, at the conclusion 
of the trial, all participants in the placebo group were given ‘open-label’ 
neostigmine, which resolved pseudo-obstruction in a further 7 partici-
pants in the control group, and in the non-responder within the treat-
ment group. A second similar study by Van der Spoel et al.3 highlighted 
the benefits of neostigmine in a group of 24 intensive care patients with 
ACPO– 11/13 patients given neostigmine resolved, compared with 0/11 
in the placebo group (p < 0.001). 
The role of colonic decompression through endoscopy has been well- 
established and adopted into practice. Initially, a retrospective cohort 
study by Tsirline et al.4 noted that endoscopic decompression was twice 
as successful at resolving pseudo-obstruction as neostigmine. Since then, 
endoscopic decompression has been adopted as a middle ground be-
tween conservative management and surgical intervention. 
Furthermore, this precedent is supported in a retrospective study by 
Peker et. Al5 who noted that, in a group of 68 patients, those undergoing 
endoscopic decompression had a higher rate of response to first treat-
ment (83.8%) compared to neostigmine treatment initially (48.4%). 
Specific concerns in this case include the potential for misdiagnosis 
of pseudo-obstruction with mechanical bowel obstruction, or iatrogenic 
bowel injury. Features such as the elevated white cell count (with pre-
dominant neutrophilia) could obfuscate the diagnosis and pre-empt 
emergent operative management. Imaging may not be definitive in 
distinguishing between mechanical and pseudo-obstruction particularly 
in the immediate post-operative period. 
The clinical examination (a lack of peritonism, and clinical stability), 
was more suggestive of a pseudo-obstruction than mechanical obstruc-
tion in this case. However, ACPO should be considered a differential 
diagnosis in patients presenting with abdominal discomfort and 
distension in the post-prostatectomy setting. As pharmacological and 
endoscopic approaches are available for management, care should be 
taken to distinguish it from mechanical obstruction or iatrogenic bowel 
injury, which may warrant prompt operative intervention. 
Given the failure of conservative management, and the implications 
of re-operation in this case (owing to recent prostatectomy), the benefit 
of endoscopic intervention is apparent. The patient’s history of ischemic 
Fig. 1. Abdominal X-Ray/CT on admission highlighting gross distension of the caecum.  
Fig. 2. CT-Abdomen with rectal contrast.  
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heart disease - a risk factor for neostigmine-related bradycardia, further 
preferences endoscopic decompression to acetylcholinesterase inhibitor 
therapy. 
4. Conclusion 
In patients presenting with atypical obstructive symptoms post 
urological surgery, a diagnosis of pseudo-obstruction should be 
considered as a cause. 
While the mechanism of pseudo-obstruction remains unclear, the 
paradigm of care is now reasonably established. Provision of bowel rest 
remains the mainstay, while endoscopic decompression is suggested as 
superior to alternatives such as neostigmine. However, moderate- 
quality evidence reveals that neostigmine (as a procholinergic) may 
play a role in management of ACPO. 
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Fig. 3. Repeat CT on Day 4 of admission, highlighting ongoing resolution of 
pseudo-obstruction. Complete clinical resolution would require a further 
three days. 
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